• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

New Staging System on Horizon for Head and Neck Cancers

by Thomas R. Collins • June 20, 2017

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

There were no changes to the T (the size and location of the primary tumor) category, but many changes to the N (nodal) category. A clinical N1 designation will mean one or more ipsilateral lymph nodes, none greater than 6 cm; a clinical N2 will be contralateral or bilateral lymph nodes, none more than 6 cm; and clinical N3 will be lymph nodes larger than 6 cm.

You Might Also Like

  • New Staging System Proposed for HPV-Related Oropharyngeal Cancer
  • Panel Discusses Case Management of Head and Neck Cancers at 2016 TRIO Combined Sections Meeting
  • ‘Patient-Centered Approach’ Delivers High-Quality Care to Patients with Head and Neck Cancers
  • Sarcopenia Significantly Associated with Poorer Overall Survival of Patients with Head and Neck Cancers
Explore This Issue
June 2017

Pathological N1 will be metastasis in four or fewer lymph nodes, and pathological N2 will be metastasis in more than four lymph nodes. There will be no pathological N3 category.

New T Category Criteria for Oral Cavity Cancer

(click for larger image)
New T Category Criteria for Oral Cavity Cancer
DOI is depth of invasion and not tumor thickness
Source: AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017

Dr. Kraus acknowledged this might make for tricky conversations between patients and clinicians, who will have to “try to tell [patients] that what is stage IV disease as we sit here in 2017 really is stage I or stage II. And it does create some challenges.”

He added that smoking was not included in the staging system, despite the evidence suggesting its effect on risk because the data were just not strong enough yet to build it in. He anticipated it would be incorporated in the next edition.

Mucosal melanoma: Dr. Kraus said the main change here was an acknowledgement of the poor outcome that most patients tend to have with this disease. There will no longer be a T1 or T2 classification, only T3, T4a, and T4b, because the outcomes are just too dire, he said. Eliminating those levels is “one of the rare times this has ever occurred in the AJCC,” he added.

“Because of the universally poor outcome, I think this an appropriate amendment. Even when you are stage 3a, you have anticipated survival that’s approximately 40%, and as you get into the 4c you ultimately approach zero over time,” Dr. Kraus said. “In spite of our efforts, this population of patients continues to do poorly.”

Unknown primary that is p16-negative: Dr. Kraus pointed out that most unknown primaries end up being positive for p16 protein, associated with HPV positivity, but that this staging involves only the p16-negative variety. A notable change in this area is that the pathologic extranodal extension (ENE) is broken into two segments: “micro” ENE with extension of no more than 2 mm, and “major” ENE with extension of more than 2 mm. Pathological ENE will increase the N stage by one level from the previous system, he said.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features Tagged With: cancer staging, cancer therapy, head and neck cancer, Triological Society annual meetingIssue: June 2017

You Might Also Like:

  • New Staging System Proposed for HPV-Related Oropharyngeal Cancer
  • Panel Discusses Case Management of Head and Neck Cancers at 2016 TRIO Combined Sections Meeting
  • ‘Patient-Centered Approach’ Delivers High-Quality Care to Patients with Head and Neck Cancers
  • Sarcopenia Significantly Associated with Poorer Overall Survival of Patients with Head and Neck Cancers

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • 22 Symptoms Common to Patients with Superior Canal Dehiscence Syndrome

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939